PATENT CLAIM ANALYSIS

Application Number: 15777333
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "282000"]

Abstract:
The present invention provides a transdermal delivery device comprising a pharmaceutical composition, wherein said composition comprises a N-oxide derivative of an opioid antagonist, or a salt thereof, and an opioid agonist or salt thereof.

Claim (Index 17):
The device as claimed in  claim 1 , wherein in said N-oxide derivative of formula (I), R 3  is selected from O, CH 2 , or N\u2014NH 2  when the dashed bond is present and is selected from the group consisting of OH, H, C 1-8  alkyl, OCOR 1 , O(CH 2 CH 2 (CH 2 ) y O) x CH 3  wherein x is 1-10 and y is 0-3, N(R 1 ) 2 , NR 1 COR, NHCOR, CONR 1 R and CONHR, wherein R is a hydrocarbyl group, when the dashed bond is absent.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.40741
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15170201', '14585438', '12786686', '12176279', '13543022']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816334310542806
- 35 USC 102 Novelty (BERT): 0.5109294252195542
- Combined Prediction Score: 0.754563030470808
- Mean Citation Score: 254.688388
- Max Citation Score: 257.35855
- Similarity Product: 177.41972144246105

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test